GlassScriptPhysician profile
Steven William Boehm
NPI 1336768530
$1,737.00
in general payments reported to CMS, 2019-2025
8 companies · $1,678 in 2025
The $1,678 reported for 2025 was more than what 79% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $43.55 · 2024: $15.90 · 2025: $1,678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,068 · Travel and Lodging: $340 · Food and Beverage: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,068.49 |
| Travel and Lodging | $340.21 |
| Food and Beverage | $284.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,416.68 | 2025 | |
| Heron Therapeutics, INC. | $109.62 | 2025 | Zynrelef |
| Astrazeneca Pharmaceuticals LP | $68.49 | 2025 | Imfinzi |
| Davol INC. | $53.62 | 2021-2025 | Phasix Mesh |
| Acera Surgical, INC. | $31.89 | 2025 | Restrata Wound Matrix |
| Baxter Healthcare | $20.81 | 2021 | |
| Tela Bio, INC. | $19.99 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Lemaitre Vascular, INC. | $15.90 | 2024 | Artegraft Vascular Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Boehm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.